VAC4EU Partners

VAC4EU and Global Vaccine Data Network™ (GVDN™)

The GVDN™, a multinational, investigator-led network, was founded in 2019 with 21 partner sites across 17 countries. They now have 23 partners across 19 countries, representing more than 250 million people, and continue to expand. They aim to:  

• Evaluate vaccine safety concerns through analysis and evaluation of large clinical databases, focusing on rare events  

• Evaluate vaccine effectiveness to facilitate risk/benefit analyses  

• Coordinate response to concerns regarding vaccines, such as vaccine hesitancy  

VAC4EU is an active member of the GVDN™. We are also regular contributors to their biannual newsletter, entitled Safety by Numbers. The purpose of this newsletter is to highlight collaboration and share data and resources to support vaccine safety communication. Our most recent contribution, from the 13th of November, includes the three most recent publications from the Covid Vaccine Monitor project, reports on the acceptance of the two protocols for the SAFETY-VAC project, and celebrates our presence at the World Vaccine Congress Europe. You can find this edition and all past issues of the newsletter in the module on the right.

European Vaccine Initiative and the Tuberculosis Vaccine Initiative

VAC4EU is proud to announce a new partnership with the European Vaccine Initiative (EVI) and the Tuberculosis Vaccine Initiative (TBVI). EVI and TBVI are both European non-profit Product Development Partnerships (PDPs) that support global efforts to develop effective and affordable vaccines. While EVI is focused on the prevention of diseases of poverty and emerging infectious diseases, TBVI is focused on tuberculosis. 

We are very interested in exchanging research and funding opportunities, collaborative fundraising efforts, networking, joint communication, and knowledge sharing with these two initiatives. We are exploring possible opportunities to co-create and collaborate on studies and topics of mutual interest (for example, European pandemic preparedness). 

We are glad to take this initial step of signing a Memorandum of Understanding and look forward to working with EVI and TBVI! 

VAC4EU and the World Vaccine Congress

World Vaccine Congresses are the largest and most established vaccine meetings of their kind across the globe, established in 2000. Featuring presentations and panel debates from industry-leading experts, exhibitions, and ample networking opportunities, topics cover everything vaccine related from basic research to commercial manufacture.  

VAC4EU will have a strong presence at the upcoming European congress, leading a working group on the use of real world evidence for vaccines, and participating in two panels: one on how to conduct post-authorization studies on vaccines deployed under emergency use authorization, and another on the importance and sustainability of public-private partnerships for vaccine development. 

We have also partnered with Terrapinn, the company that organises the World Vaccine Congress events, to offer a discount for our members. 

VAC4EU and SIGMA

We are pleased to announce that VAC4EU and the SIGMA Consortium have formally joined forces and expressed our shared vision and a mutual goal to continue collaborating, developing existing synergies, and sharing expertise and knowledge, information, and tools developed by the two networks for pharmacoepidemiology/real-world evidence studies and activities.
SIGMA Consortium is a contract-based alliance of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) research centers launched on 11th November 2011. It is being launched to enable multi-country studies using common analyses to study responses to treatments in large populations, and to clarify and quantify these treatment effects for the citizens of Europe.

VAC4EU and ACN

Active Citizenship Network (ACN) was initiated in December 2001 as the European and international interface of the Italian civic participation organization Cittadinanzattiva (Active Citizenship). ACN is a flexible network of European civic organizations which are involved as partners in its different projects, addressed to encourage active participation of citizens in European policy-making.  

At the beginning of 2022, a collaboration between VAC4EU and CAN was established. The 3 major objectives of a fair collaboration between the 2 organizations are:  

• To explore common training activities and/or how to participate in each other’s training program  

• To identify project calls to which both organizations could apply together, leveraging each other’s expertise  

• To build trust and collaboration to increase access to information on vaccines with the scientifically independent support from VAC4EU and the citizens outreach from ACN